Skip to Content

71 Results Found

  • Case Report
  • Open Access
7 Citations
1,226 Views
4 Pages

12 March 2019

Essential thrombocythemia (ET) is a clonal bone marrow disease, characterized by increased production of platelets along with other clinical and bone marrow findings. Most patients with ET will have a somatic mutation in one of the known gene locatio...

  • Case Report
  • Open Access
2 Citations
2,888 Views
8 Pages

Additional Genetic Alterations and Clonal Evolution of MPNs with Double Mutations on the MPL Gene: Two Case Reports

  • Maria Stella Pennisi,
  • Sandra Di Gregorio,
  • Elena Tirrò,
  • Chiara Romano and ,
  • Andrea Duminuco,
  • Bruno Garibaldi,
  • Gaetano Giuffrida,
  • Livia Manzella,
  • Paolo Vigneri and
  • Giuseppe A. Palumbo
  • + 5 authors+ 0 author

Essential thrombocythemia (ET) and primary myelofibrosis (PMF) are two of the main BCR-ABL1-negative chronic myeloproliferative neoplasms (MPNs) characterized by abnormal megakaryocytic proliferation. Janus kinase 2 (JAK2) mutations are detected in 5...

  • Feature Paper
  • Article
  • Open Access
5 Citations
3,602 Views
17 Pages

Transcriptomic Analysis Reveals JAK2/MPL-Independent Effects of Calreticulin Mutations in a C. elegans Model

  • Ana Guijarro-Hernández,
  • Laura Eder-Azanza,
  • Cristina Hurtado,
  • David Navarro-Herrera and ,
  • Begoña Ezcurra,
  • Francisco Javier Novo,
  • Juan Cabello and
  • José Luis Vizmanos
  • + 3 authors+ 0 author

2 January 2023

There is growing evidence that Ph-negative myeloproliferative neoplasms (MPNs) are disorders in which multiple molecular mechanisms are significantly disturbed. Since their discovery, CALR driver mutations have been demonstrated to trigger pathogenic...

(This article belongs to the Special Issue Research Advances in Invertebrate Experimental Models of Malignant Growth)
  • Article
  • Open Access
20 Citations
4,820 Views
14 Pages

Clinical and Laboratory Features of JAK2 V617F, CALR, and MPL Mutations in Malaysian Patients with Classical Myeloproliferative Neoplasm (MPN)

  • Razan Hayati Zulkeflee,
  • Zefarina Zulkafli,
  • Muhammad Farid Johan,
  • Azlan Husin and ,
  • Md Asiful Islam and
  • Rosline Hassan
  • + 1 author+ 0 author

Mutations of JAK2V617F, CALR, and MPL genes confirm the diagnosis of myeloproliferative neoplasm (MPN). This study aims to determine the genetic profile of JAK2V617F, CALR exon 9 Type 1 (52 bp deletion) and Type 2 (5 bp insertion), and MPL W515 L/K g...

  • Article
  • Open Access
1 Citations
5,522 Views
9 Pages

Background and Objectives: Philadelphia (Ph)-negative myeloproliferative neoplasms can exhibit defects in Janus kinase 2 (JAK2), Calreticulin (CalR), and MPL genes. It is possible that the presence of other driver mutations may influence diagnosis an...

(This article belongs to the Topic Cancer Biology and Radiation Therapy: 2nd Edition)
  • Article
  • Open Access
7 Citations
4,821 Views
12 Pages

Low JAK2 V617F Allele Burden in Ph-Negative Chronic Myeloproliferative Neoplasms Is Associated with Additional CALR or MPL Gene Mutations

  • Tatiana V. Makarik,
  • Adhamjon O. Abdullaev,
  • Elena E. Nikulina,
  • Svetlana A. Treglazova and ,
  • Elena E. Stepanova,
  • Irina N. Subortseva,
  • Alla M. Kovrigina,
  • Anait L. Melikyan,
  • Sergei M. Kulikov and
  • Andrey B. Sudarikov
  • + 5 authors+ 0 author

12 April 2021

JAK2 (Janus kinase 2) V617F, CALR (Calreticulin) exon 9, and MPL (receptor for thrombopoietin) exon 10 mutations are associated with the vast majority of Ph-negative chronic myeloproliferative neoplasms (MPNs). These mutations affect sequential stage...

(This article belongs to the Section Molecular Genetics and Genomics)
  • Feature Paper
  • Review
  • Open Access
18 Citations
5,530 Views
23 Pages

Integration of Molecular Information in Risk Assessment of Patients with Myeloproliferative Neoplasms

  • Giuseppe G. Loscocco,
  • Giacomo Coltro,
  • Paola Guglielmelli and
  • Alessandro M. Vannucchi

2 August 2021

Philadelphia chromosome-negative myeloproliferative neoplasms (MPN) are clonal disorders of a hematopoietic stem cell, characterized by an abnormal proliferation of largely mature cells driven by mutations in JAK2, CALR, and MPL. All these mutations...

(This article belongs to the Special Issue Myeloproliferative Neoplasms: From Genetic Landscape to Therapeutic Targets)
  • Case Report
  • Open Access
8 Citations
1,024 Views
3 Pages

2 November 2016

Refractory anemia with ring sideroblasts associated with marked thrombocytosis (RARS-T) is a hematologic malignancy that often results in transfusion dependency and a hypercoagulable state. This rare disease currently lacks formal guidelines for trea...

  • Article
  • Open Access
603 Views
13 Pages

Unmasking Additional Mutations: A Single Institution Study in Myeloproliferative Neoplasms

  • Parastou Tizro,
  • Eric Vail,
  • Manoj Sapkota,
  • Matthew G. Gayhart and
  • Celeste C. Eno

31 July 2026

Background/Objectives: Myeloproliferative neoplasms (MPNs) are chronic myeloid malignancies characterized by substantial genetic heterogeneity. Although routine molecular evaluation focuses on canonical driver alterations (BCR::ABL1, JAK2, CALR, and...

(This article belongs to the Section Cancer Biomarkers)
  • Review
  • Open Access
53 Citations
9,478 Views
32 Pages

14 August 2020

Myeloproliferative neoplasms (MPNs) constitute a group of disorders identified by an overproduction of cells derived from myeloid lineage. The majority of MPNs have an identifiable driver mutation responsible for cytokine-independent proliferative si...

(This article belongs to the Special Issue Pathophysiology and Molecular Targets in Myeloid Neoplasia)
  • Article
  • Open Access
14 Citations
4,350 Views
14 Pages

Two Triacylglycerol Lipases Are Negative Regulators of Chilling Stress Tolerance in Arabidopsis

  • Ling Wang,
  • Bilian Qian,
  • Lei Zhao,
  • Ming-Hua Liang and ,
  • Xiangqiang Zhan and
  • Jianhua Zhu
  • + 1 author+ 0 author

Cold stress is one of the abiotic stress conditions that severely limit plant growth and development and productivity. Triacylglycerol lipases are important metabolic enzymes for the catabolism of triacylglycerols and, therefore, play important roles...

(This article belongs to the Special Issue Abiotic Stress: Signaling and Responses)
  • Article
  • Open Access
4 Citations
2,772 Views
23 Pages

23 November 2023

The thrombopoietin receptor (MPL) gene is a critical regulator of hematopoiesis, and any alterations in its structure or function can result in a range of hematological disorders. Non-synonymous single nucleotide polymorphisms (nsSNPs) in MPL have th...

(This article belongs to the Special Issue Structure and Function of Proteins: From Bioinformatics Insights)
  • Review
  • Open Access
10 Citations
5,544 Views
17 Pages

21 September 2023

Myelofibrosis (MF) is a clonal myeloproliferative neoplasm (MPN) characterized clinically by cytopenias, fatigue, and splenomegaly stemming from extramedullary hematopoiesis. MF commonly arises from mutations in JAK2, MPL, and CALR, which manifests a...

(This article belongs to the Section Clinical Research in Cancer)
  • Article
  • Open Access
5 Citations
5,088 Views
16 Pages

Multiplex RT Real-Time PCR Based on Target Failure to Detect and Identify Different Variants of SARS-CoV-2: A Feasible Method That Can Be Applied in Clinical Laboratories

  • Van Hung Pham,
  • Huong Thien Pham,
  • Mario G. Balzanelli,
  • Pietro Distratis and ,
  • Rita Lazzaro,
  • Quoc Viet Nguyen,
  • Viet Quoc Tran,
  • Duy Khanh Tran,
  • Luan Duy Phan and
  • Ciro Gargiulo Isacco
  • + 18 authors+ 13 authors

Shortly after its emergence, Omicron and its sub-variants have quickly replaced the Delta variant during the current COVID-19 outbreaks in Vietnam and around the world. To enable the rapid and timely detection of existing and future variants for epid...

(This article belongs to the Section Pathology and Molecular Diagnostics)
  • Review
  • Open Access
13 Citations
6,326 Views
29 Pages

Molecular Genetics of Thrombotic Myeloproliferative Neoplasms: Implications in Precision Oncology

  • Yuh Cai Chia,
  • Mat Jusoh Siti Asmaa,
  • Marini Ramli,
  • Peng Yeong Woon and ,
  • Muhammad Farid Johan,
  • Rosline Hassan and
  • Md Asiful Islam
  • + 2 authors+ 0 author

Classical BCR-ABL-negative myeloproliferative neoplasms (MPN) include polycythaemia vera, essential thrombocythaemia, and primary myelofibrosis. Unlike monogenic disorders, a more complicated series of genetic mutations are believed to be responsible...

(This article belongs to the Special Issue Advances in the Diagnosis and Management of Tumors/Cancers)
  • Review
  • Open Access
2 Citations
5,318 Views
14 Pages

9 October 2021

Somatic mutations in JAK2, calreticulin, and MPL genes drive myeloproliferative neoplasms (MPN), and recent technological advances have revealed a heterogeneous genomic landscape with additional mutations in MPN. These mainly affect genes involved in...

(This article belongs to the Special Issue Recent Developments of Hematologic Diagnostics in the Interplay with Evolving Treatment Developments)
  • Review
  • Open Access
3 Citations
5,241 Views
22 Pages

Biological Markers of Myeloproliferative Neoplasms in Children, Adolescents and Young Adults

  • Aleksandra Ozygała,
  • Joanna Rokosz-Mierzwa,
  • Paulina Widz,
  • Paulina Skowera and ,
  • Mateusz Wiliński,
  • Borys Styka and
  • Monika Lejman
  • + 2 authors+ 0 author

8 December 2024

Myeloproliferative neoplasms (MPNs) are clonal hematopoietic cancers characterized by hyperproliferation of the myeloid lineages. These clonal marrow disorders are extremely rare in pediatric patients. MPN is reported to occur 100 times more frequent...

(This article belongs to the Special Issue Cancer Genetics and Epigenetics: Their Roles and Clinical Implications)
  • Article
  • Open Access
1,124 Views
14 Pages

Comprehensive High-Sensitivity Mutation Profiling in MPNs: Diagnostic and Prognostic Implications

  • Namsoo Kim,
  • Yehyun Kang,
  • Hye Won Kook,
  • Haerim Chung and ,
  • Ji Eun Jang,
  • Seung-Tae Lee,
  • Jaewoo Song,
  • Jin Seok Kim,
  • Jong Rak Choi and
  • Saeam Shin
  • + 6 authors+ 1 author

14 August 2026

Background/Objectives: Myeloproliferative neoplasms (MPNs) are clonal hematopoietic stem cell disorders driven by somatic mutations, most commonly those in JAK2, CALR, and MPL. While conventional molecular testing often focuses on these canonical mut...

(This article belongs to the Special Issue Diagnosis and Treatment of Myeloid Neoplasms)
  • Review
  • Open Access
4 Citations
3,880 Views
12 Pages

Impact of Molecular Biology in Diagnosis, Prognosis, and Therapeutic Management of BCR::ABL1-Negative Myeloproliferative Neoplasm

  • Norman Abbou,
  • Pauline Piazzola,
  • Jean Gabert,
  • Vincent Ernest and ,
  • Robin Arcani,
  • Anne-Laure Couderc,
  • Antoine Tichadou,
  • Pauline Roche,
  • Laure Farnault and
  • Geoffroy Venton
  • + 9 authors+ 4 authors

27 December 2022

BCR::ABL1-negative myeloproliferative neoplasms (MPNs) include three major subgroups—polycythemia vera (PV), essential thrombocythemia (ET), and primary myelofibrosis (PMF)—which are characterized by aberrant hematopoietic proliferation w...

(This article belongs to the Section Cellular Pathology)
  • Brief Report
  • Open Access
1 Citations
2,237 Views
7 Pages

Whole Exome Sequencing of Adult Indians with Apparently Acquired Aplastic Anaemia: Initial Experience at Tertiary Care Hospital

  • Sudhir Mehta,
  • Krishna Mohan Medicherla,
  • Sandhya Gulati,
  • Nidhi Sharma and ,
  • Rabia Parveen,
  • Ashwani Kumar Mishra,
  • Sonal Gupta and
  • Prashanth Suravajhala
  • + 3 authors+ 0 author

23 September 2024

Aplastic anaemia (AA) is a rare hypocellular bone marrow disease with a large number of mutations in the telomerase reverse transcriptase gene (TERT), leading to bone marrow failure. We used our benchmarked whole exome sequencing (WES) pipeline to id...

  • Review
  • Open Access
21 Citations
7,713 Views
22 Pages

Murine Models of Myelofibrosis

  • Sebastien Jacquelin,
  • Frederike Kramer,
  • Ann Mullally and
  • Steven W. Lane

23 August 2020

Myelofibrosis (MF) is subtype of myeloproliferative neoplasm (MPN) characterized by a relatively poor prognosis in patients. Understanding the factors that drive MF pathogenesis is crucial to identifying novel therapeutic approaches with the potentia...

(This article belongs to the Special Issue New Insights into Myeloproliferative Neoplasms)
  • Review
  • Open Access
14 Citations
5,256 Views
22 Pages

30 October 2021

Chronic myeloproliferative neoplasms (MPNs) are hematopoietic stem cell neoplasms with driver events including the BCR-ABL1 translocation leading to a diagnosis of chronic myeloid leukemia (CML), or somatic mutations in JAK2, CALR, or MPL resulting i...

(This article belongs to the Special Issue Molecular Pathways in Hematologic Neoplasm)
  • Article
  • Open Access
4 Citations
2,611 Views
12 Pages

ADAMTS13, von Willebrand Factor, Platelet Microparticles, Factor VIII, and Impact of Somatic Mutations in the Pathogenesis of Splanchnic Vein Thrombosis Associated with BCR-ABL-Negative Myeloproliferative Neoplasms

  • Roberto Castelli,
  • Alessandra Berzuini,
  • Roberto Manetti,
  • Alessandro Palmerio Delitala and ,
  • Dante Castro,
  • Giuseppe Sanna,
  • Marta Chiara Sircana,
  • Nicia Isabella Profili,
  • Arianna Bartoli and
  • Antonio Gidaro
  • + 8 authors+ 3 authors

9 April 2024

Background: Myeloproliferative neoplasms (MPNs) are often associated with splanchnic vein thrombosis (SVT). Not all the factors involved in the thrombotic tendency are currently known. Objectives: This study aims to evaluate a possible association be...

(This article belongs to the Special Issue Vascular Disease: Etiologic, Diagnostic, Prognostic and Therapeutic Research—2nd Edition)
  • Review
  • Open Access
35 Citations
7,305 Views
39 Pages

6 August 2020

The myeloproliferative neoplasms (MPNs) are acquired hematological stem cell neoplasms characterized by driver mutations in JAK2, CALR, or MPL. Additive mutations may appear in predominantly epigenetic regulator, RNA splicing and signaling pathway ge...

(This article belongs to the Special Issue New Insights into Myeloproliferative Neoplasms)
  • Review
  • Open Access
44 Citations
8,880 Views
13 Pages

JAK2 in Myeloproliferative Neoplasms: Still a Protagonist

  • Michael Stephan Bader and
  • Sara Christina Meyer

28 January 2022

The discovery of the activating V617F mutation in Janus kinase 2 (JAK2) has been decisive for the understanding of myeloproliferative neoplasms (MPN). Activated JAK2 signaling by JAK2, CALR, and MPL mutations has become a focus for the development of...

(This article belongs to the Special Issue The Regulation of JAKs in Health and in Disease)
  • Review
  • Open Access
2 Citations
4,161 Views
14 Pages

21 August 2023

BCR::ABL1-negative myeloproliferative neoplasms (MPNs) are a group of hematopoietic malignancies in which somatic mutations are acquired in hematopoietic stem/progenitor cells, resulting in an abnormal increase in blood cells in peripheral blood and...

(This article belongs to the Special Issue Molecular Research on Myeloproliferative Disorders)
  • Review
  • Open Access
29 Citations
5,867 Views
21 Pages

28 July 2020

Myeloproliferative neoplasms (MPNs) are associated with the fewest number of mutations among known cancers. The mutations propelling these malignancies are phenotypic drivers providing an important implement for diagnosis, treatment response monitori...

(This article belongs to the Special Issue New Insights into Myeloproliferative Neoplasms)
  • Article
  • Open Access
47 Citations
7,392 Views
22 Pages

Identification of Novel phoP-phoQ Regulated Genes that Contribute to Polymyxin B Tolerance in Pseudomonas aeruginosa

  • Baopeng Yang,
  • Chang Liu,
  • Xiaolei Pan,
  • Weixin Fu and ,
  • Zheng Fan,
  • Yongxin Jin,
  • Fang Bai,
  • Zhihui Cheng and
  • Weihui Wu
  • + 4 authors+ 0 author

Polymyxin B and E (colistin) are the last resorts to treat multidrug-resistant Gram-negative pathogens. Pseudomonas aeruginosa is intrinsically resistant to a variety of antibiotics. The PhoP-PhoQ two-component regulatory system contributes to the re...

(This article belongs to the Special Issue Antimicrobial Resistance in Pseudomonas aeruginosa)
  • Article
  • Open Access
3 Citations
2,338 Views
8 Pages

Achromobacter species are emerging pathogens in cystic fibrosis with inherent resistance to several classes of antimicrobial agents. We exposed strains with wild-type antimicrobial susceptibility to ticarcillin and generated mutants with broad β...

(This article belongs to the Section Medical Microbiology)
  • Brief Report
  • Open Access
5 Citations
5,681 Views
5 Pages

Triple-Negativity Identifies a Subgroup of Patients with Better Overall Survival in Essential Thrombocythemia

  • Marco Santoro,
  • Vincenzo Accurso,
  • Salvatrice Mancuso,
  • Mariasanta Napolitano and ,
  • Marta Mattana,
  • Giorgia Vajana,
  • Federica Russello and
  • Sergio Siragusa
  • + 3 authors+ 0 author

24 August 2022

Essential thrombocythemia, as defined by the WHO in 2016, is a Philadelphia-negative chronic myeloproliferative neoplasm showing a better prognosis than polycythemia vera and myelofibrosis. In a variable percentage, patients with essential thrombocyt...

(This article belongs to the Special Issue Personalized Therapy and Clinical Outcomes for Congenital and Acquired Haemorrhagic Disorders, Thromboembolic Disease and Platelet Disorders)
  • Review
  • Open Access
11 Citations
4,498 Views
15 Pages

The Role of Neutrophilic Granulocytes in Philadelphia Chromosome Negative Myeloproliferative Neoplasms

  • Dominik Kiem,
  • Sandro Wagner,
  • Teresa Magnes,
  • Alexander Egle and ,
  • Richard Greil and
  • Thomas Melchardt
  • + 1 author+ 0 author

3 September 2021

Philadelphia chromosome negative myeloproliferative neoplasms (MPN) are composed of polycythemia vera (PV), essential thrombocytosis (ET), and primary myelofibrosis (PMF). The clinical picture is determined by constitutional symptoms and complication...

(This article belongs to the Section Molecular Immunology)
  • Review
  • Open Access
24 Citations
10,697 Views
19 Pages

Molecular Pathogenesis of Myeloproliferative Neoplasms: From Molecular Landscape to Therapeutic Implications

  • Erika Morsia,
  • Elena Torre,
  • Antonella Poloni,
  • Attilio Olivieri and
  • Serena Rupoli

Despite distinct clinical entities, the myeloproliferative neoplasms (MPN) share morphological similarities, propensity to thrombotic events and leukemic evolution, and a complex molecular pathogenesis. Well-known driver mutations, JAK2, MPL and CALR...

(This article belongs to the Section Molecular Biology)
  • Review
  • Open Access
22 Citations
8,530 Views
12 Pages

The JAK2 GGCC (46/1) Haplotype in Myeloproliferative Neoplasms: Causal or Random?

  • Luisa Anelli,
  • Antonella Zagaria,
  • Giorgina Specchia and
  • Francesco Albano

The germline JAK2 haplotype known as “GGCC or 46/1 haplotype” (haplotypeGGCC_46/1) consists of a combination of single nucleotide polymorphisms (SNPs) mapping in a region of about 250 kb, extending from the JAK2 intron 10 to the Insulin-like 4 (INLS4...

(This article belongs to the Section Biochemistry)
  • Review
  • Open Access
32 Citations
4,336 Views
17 Pages

Myeloproliferative neoplasms (MPNs), encompassing disorders like polycythemia vera (PV), essential thrombocythemia (ET), and primary myelofibrosis (PMF), are characterized by clonal hematopoiesis without the Philadelphia chromosome. The JAK2 V617F mu...

(This article belongs to the Special Issue A Focus on the Molecular Basis of Cardiovascular Diseases)
  • Proceeding Paper
  • Open Access
1,922 Views
7 Pages

Preclinical Investigation of Inhibition of the DNA Damage Response as a Targetted Therapy in Myeloproliferative Neoplasms Shows Synergism of ATR Inhibitors with Standard-of-Care Treatment

  • Aleksander Ślusarczyk,
  • Helen E. Bryant,
  • Edwin Chen,
  • Ian Hitchcock and ,
  • Martin Zeidler,
  • Andrew Chantry and
  • Sally Thomas
  • + 2 authors+ 0 author

Myeloproliferative neoplasms (MPNs) are a group of haematological malignancies arising from haematopoietic stem cells (HSCs) with acquired driver mutations in JAK2, MPL and CALR. Current therapies are not selective for the mutant HSC population. Incr...

(This article belongs to the Proceedings of The 1st International Electronic Conference on Cancers: Exploiting Cancer Vulnerability by Targeting the DNA Damage Response)
  • Review
  • Open Access
21 Citations
6,426 Views
14 Pages

The Genetic Basis of Primary Myelofibrosis and Its Clinical Relevance

  • Elisa Rumi,
  • Chiara Trotti,
  • Daniele Vanni,
  • Ilaria Carola Casetti and ,
  • Daniela Pietra and
  • Emanuela Sant’Antonio
  • + 1 author+ 0 author

24 November 2020

Among classical BCR-ABL-negative myeloproliferative neoplasms (MPN), primary myelofibrosis (PMF) is the most aggressive subtype from a clinical standpoint, posing a great challenge to clinicians. Whilst the biological consequences of the three MPN dr...

(This article belongs to the Section Molecular Pathology, Diagnostics, and Therapeutics)
  • Article
  • Open Access
3 Citations
3,195 Views
31 Pages

The Role of Mutated Calreticulin in the Pathogenesis of BCR-ABL1-Negative Myeloproliferative Neoplasms

  • Roberta Vadeikienė,
  • Baltramiejus Jakštys,
  • Danguolė Laukaitienė,
  • Saulius Šatkauskas and ,
  • Elona Juozaitytė and
  • Rasa Ugenskienė
  • + 1 author+ 0 author

12 September 2024

Myeloproliferative neoplasms (MPNs) are characterized by increased proliferation of myeloid lineages in the bone marrow. Calreticulin (CALR) 52 bp deletion and CALR 5 bp insertion have been identified in essential thrombocythemia (ET) and primary mye...

(This article belongs to the Special Issue Hematological Malignancies: Molecular Mechanisms and Therapy)
  • Article
  • Open Access
991 Views
18 Pages

NFE2 Truncation Mutants Protect Wild-Type NFE2 from ITCH-Dependent Degradation

  • Mirjam Elisabeth Hoeness,
  • Franziska Zell,
  • Titiksha Basu,
  • Katharina Gellrich and ,
  • Albert Gründer,
  • Jana Schulze,
  • Anja Müller,
  • Philipp Eble,
  • Christoph Koellerer and
  • Hans Felix Staehle
  • + 8 authors+ 3 authors

16 December 2025

Myeloproliferative neoplasms (MPNs) are clonal hematopoietic disorders characterized by the abnormal proliferation of myeloid cells. In addition to the main driver mutations in JAK2, MPL, and CALR, the transcription factor nuclear factor erythroid 2...

(This article belongs to the Special Issue Hematological Malignancies: Molecular Mechanisms and Therapy, 2nd Edition)
  • Article
  • Open Access
11 Citations
4,208 Views
20 Pages

Clinical Features, Gene Alterations, and Outcomes in Prefibrotic and Overt Primary and Secondary Myelofibrotic Patients

  • Tong-Yoon Kim,
  • Daehun Kwag,
  • Jong-Hyuk Lee,
  • Joonyeop Lee and ,
  • Gi-June Min,
  • Sung-Soo Park,
  • Silvia Park,
  • Young-Woo Jeon,
  • Jae-Ho Yoon and
  • Sung-Eun Lee
  • + 17 authors+ 12 authors

16 September 2022

The Philadelphia-negative myeloproliferative neoplasms (MPNs) are divided in three major groups: polycythemia vera (PV), essential thrombocythemia (ET), and primary myelofibrosis (PMF). The 2016 WHO classification incorporates also prefibrotic PMF (p...

  • Review
  • Open Access
296 Views
14 Pages

20 October 2026

BCR::ABL1 negative myeloproliferative neoplasms (MPN) are driven predominantly by somatic mutations in JAK2, CALR, and MPL, which underpin diagnosis, prognostication, and measurable residual disease (MRD) monitoring. Advances in molecular assays have...

(This article belongs to the Special Issue Hematologic Malignancies: Clinical Features and Prognostic Indicators)
  • Review
  • Open Access
23 Citations
16,969 Views
17 Pages

18 January 2022

Myeloproliferative neoplasms (MPN) are a group of blood cancers in which the bone marrow (BM) produces an overabundance of erythrocyte, white blood cells, or platelets. Philadelphia chromosome-negative MPN has three subtypes, including polycythemia v...

(This article belongs to the Topic Blood Physiology: Molecular Mechanisms of Vascular Wall Functioning)
  • Review
  • Open Access
10 Citations
4,758 Views
19 Pages

Novel Molecular Insights into Leukemic Evolution of Myeloproliferative Neoplasms: A Single Cell Perspective

  • Sebastiano Rontauroli,
  • Chiara Carretta,
  • Sandra Parenti,
  • Matteo Bertesi and
  • Rossella Manfredini

3 December 2022

Myeloproliferative neoplasms (MPNs) are clonal disorders originated by the serial acquisition of somatic mutations in hematopoietic stem/progenitor cells. The major clinical entities are represented by polycythemia vera (PV), essential thrombocythemi...

(This article belongs to the Special Issue Molecular Advances in Cancer Genetics)
  • Systematic Review
  • Open Access
30 Citations
7,142 Views
24 Pages

26 February 2021

Ph-negative myeloproliferative neoplasms (polycythemia vera (PV), essential thrombocythemia (ET) and primary myelofibrosis (PMF)) are infrequent blood cancers characterized by signaling aberrations. Shortly after the discovery of the somatic mutation...

(This article belongs to the Special Issue Molecular Pathways in Cancers)
  • Review
  • Open Access
10 Citations
9,250 Views
27 Pages

Advances in the Diagnosis and Treatment of Myeloproliferative Neoplasms (MPNs)

  • Xinyu Ma,
  • Zhibo Zhou,
  • Shuyu Gu,
  • Yan Guo and ,
  • Tianqing Zhou,
  • Ruonan Shao,
  • Jinsong Yan,
  • Wei Chen and
  • Xiaofeng Shi
  • + 4 authors+ 0 author

27 September 2025

Myeloproliferative neoplasms (MPNs) encompass three principal subtypes: polycythemia vera (PV), essential thrombocythemia (ET), and primary myelofibrosis (PMF). These hematologic malignancies originate from clonal hematopoietic stem cells (HSCs) and...

(This article belongs to the Special Issue Novel Advances in the Molecular Understanding of Myeloproliferative Neoplasms (MPNs))
  • Review
  • Open Access
19 Citations
7,284 Views
14 Pages

Essential Thrombocythemia in Children and Adolescents

  • Maria Caterina Putti,
  • Irene Bertozzi and
  • Maria Luigia Randi

6 December 2021

This paper reviews the features of pediatric essential thrombocythemia (ET). ET is a rare disease in children, challenging pediatric and adult hematologists alike. The current WHO classification acknowledges classical Philadelphia-negative MPNs and d...

(This article belongs to the Special Issue Pathogenesis and Natural History of Myeloproliferative Neoplasms)
  • Article
  • Open Access
6 Citations
5,739 Views
19 Pages

28 September 2024

Background: Desmoid-type fibromatosis (DTF) is a locally aggressive myofibroblastic/fibroblastic neoplasm with a high risk of local recurrence. It has a variety of histologic features that might confuse diagnosis, especially when detected during core...

(This article belongs to the Special Issue Histopathology in Cancer Diagnosis and Prognosis)
  • Review
  • Open Access
13 Citations
11,675 Views
22 Pages

26 April 2024

Myeloproliferative neoplasms (MPNs), including Polycythemia Vera (PV), Essential Thrombocythemia (ET), and Primary Myelofibrosis (PMF), are characterized by the clonal proliferation of hematopoietic stem cells leading to an overproduction of hematopo...

(This article belongs to the Special Issue Molecular and Genetic Diagnosis and Targeted Therapy of Myeloproliferative Neoplasms)
  • Review
  • Open Access
6 Citations
4,450 Views
13 Pages

11 January 2024

Myeloproliferative neoplasms (MPNs) are hematopoietic diseases characterized by the clonal expansion of single or multiple lineages of differentiated myeloid cells that accumulate in the blood and bone marrow. MPNs are grouped into distinct categorie...

(This article belongs to the Section Tumor Microenvironment)
  • Review
  • Open Access
43 Citations
4,521 Views
18 Pages

Synergic Crosstalk between Inflammation, Oxidative Stress, and Genomic Alterations in BCR–ABL-Negative Myeloproliferative Neoplasm

  • Alessandro Allegra,
  • Giovanni Pioggia,
  • Alessandro Tonacci,
  • Marco Casciaro and ,
  • Caterina Musolino and
  • Sebastiano Gangemi
  • + 1 author+ 0 author

23 October 2020

Philadelphia-negative chronic myeloproliferative neoplasms (MPNs) have recently been revealed to be related to chronic inflammation, oxidative stress, and the accumulation of reactive oxygen species. It has been proposed that MPNs represent a human i...

  • Review
  • Open Access
7 Citations
7,177 Views
23 Pages

Cytological Diagnosis of Classic Myeloproliferative Neoplasms at the Age of Molecular Biology

  • Sophie Combaluzier,
  • Julie Quessada,
  • Norman Abbou,
  • Robin Arcani and ,
  • Antoine Tichadou,
  • Jean Gabert,
  • Régis Costello,
  • Marie Loosveld,
  • Geoffroy Venton and
  • Yaël Berda-Haddad
  • + 5 authors+ 0 author

20 March 2023

Myeloproliferative neoplasms (MPN) are clonal hematopoietic stem cell-derived disorders characterized by uncontrolled proliferation of differentiated myeloid cells. Two main groups of MPN, BCR::ABL1-positive (Chronic Myeloid Leukemia) and BCR::ABL1-n...

(This article belongs to the Section Cellular Pathology)

of 2